Previous 10 | Next 10 |
Shares of Pfizer (NYSE: PFE) dropped 14.4% in June according to data provided by S&P Global Market Intelligence , which is a pretty s ubstantial drop for a pharmaceutical giant with a current market cap of around $190 billion. Much of the d ecline is tied to a clinical trial f...
Every month I post my portfolio update, highlighting my holdings, my position weightings, my cost basis, and most importantly, my dividend growth results. I like to do this because it enables readers the chance to follow along with my dividend growth journey. As many of you know, I'm a fai...
Are These The Best Biotech Stocks To Buy For The Second Half Of 2020? Biotech stocks have outperformed the broader market year to date. Biotech stocks have also proved to be one of the most interesting spaces to watch when it comes to massive breakouts overnight. This leads investors to look...
Turning Point Therapeutics (NASDAQ: TPTX) on Tuesday licensed Greater China rights to its tyrosine kinase inhibitor, repotrectinib, to Zai Lab (NASDAQ: ZLAB) for $25 million in cash up front, plus up to $151 million in development, regulatory and sales milestones, and tiered mid-to...
July 7, 2020 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – July 7, 2020 – Tobacco use has continued to grow steadily since its humble beginnings, fueled by the mass marketing of cigarettes in the 20th century. Nowadays, h...
The stock market continues to rise and dividend income keeps coming in. The uncertainty is still significantly high and the direction the stock market is going does not make sense. However, dividend income continues to fuel the mission to financial freedom. In June, we set another record for...
Will an anti- COVID-19 vaccine be effective? Much has been written about the potential of multiple vaccines to ultimately prevent COVID-19, the condition caused by the SARS-CoV-2 coronavirus. However, despite Operation Warp Speed and the immense hyperbole surrounding vaccine candidates in...
On May 15th, we started tracking our model " All Weather Dividends Portfolio ", here on Seeking Alpha. The goal was to start displaying the way we manage our portfolios by creating a dividend portfolio from scratch, with a fictional $100,000 and $2,000 per month extra contributions. Source:...
Another month is in the books. You know what that means... another step towards financial freedom. In general, June was a pretty laid back month for me in terms of portfolio management. I suppose this is a good thing because I've been very busy with work on various projects, so I'm happy tha...
Healthcare Sector Strength The COVID-19 pandemic has been with us for several months now, and the profound impact it is having on the stock market and economy is still a fluid situation. The industrial, utility, financial, and energy sectors remain deep in correction territory, with all ...
News, Short Squeeze, Breakout and More Instantly...
2024-05-05 06:55:00 ET Don't believe the adage to "sell in May and go away." Buying stocks can still be a smart move, especially if you're a long-term investor. Three Motley Fool contributors have identified stocks they think are no-brainers to buy in May. Here's why they picked Eli L...
2024-05-04 06:45:00 ET Weight loss translates to investor profits. Just look at Eli Lilly and Novo Nordisk . Both stocks have skyrocketed thanks largely to their obesity drugs, with Lilly's share price more than quadrupling and Novo's shares more than tripling over the last three ye...
Pfizer Inc (NYSE:PFE) reported first-quarter earnings Wednesday with adjusted EPS of 82 cents. That’s down 33% year-over-year, beating the ...